Modulation of Biomarkers By BET Inhibitor, BMS-986158, Including JAK2 Variant Allele Frequency ( VAF), Bone Marrow (BM) Fibrosis, and Reversal of Abnormal Cytokine Production in Intermediate- or High-Risk Myelofibrosis (MF)-MedSci.cn

Modulation of Biomarkers By BET Inhibitor, BMS-986158, Including JAK2 Variant Allele Frequency ( VAF), Bone Marrow (BM) Fibrosis, and Reversal of Abnormal Cytokine Production in Intermediate- or High-Risk Myelofibrosis (MF)

Lee-Hoeflich, ST; Brueckner, C; Litalien, L; Xu, K; Das, S; Corella, L; Daouti, S; Esposito, O; Lees, E; Liu, Y; Nikolova, Z; Tehlirian, C; Coker, S; Wu, B

BLOOD, 2023; 142 ():

科室
- - 订阅+
  - 更多科室
工具
服务